Background: Multiple causes of false-positive chromogranin A (CgA) measurement have been reported that may affect its impact as a surrogate marker of RECIST progression in well-differentiated gastroenteropancreatic neuroendocrine tumors (WDGEPNET). ?
Aims: 1) To evaluate the frequency of false-positive CgA results. 2) To prospectively compare CgA variations with RECIST morphological changes in patients without known causes of false-positive CgA measurements.?
Methods: First, the conditions responsible for potentially false-positive CgA measurements were screened in 184 consecutive patients with metastatic WDGEPNET. Secondly, a variation in CgA at a 6-month interval was compared to RECIST results at 6 months in 46 patients.?
Results: Among 184 patients, elevated CgA was found in 130 cases (71%) including 99 patients with at least one cause of a false-positive result. Impaired kidney function as well as medication with proton pump inhibitors were found to be the 2 major causes of false-positive results. The sensitivity and specificity of CgA measurements compared with morphological tumor changes according to the RECIST criteria were 71% and 50%, respectively, at 6 months.?
Conclusion: Routine screening for the causes of false-positive CgA measurements is mandatory in WDGEPNET patients. Our study does not validate the use of CgA as a surrogate marker of tumor progression.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5301/JBM.2011.8327 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Tumour Biol
March 2024
Department of Laboratory Medicine, Althaia Xarxa Assistencial Universitària de Manresa, Manresa, Catalonia, Spain.
Article Synopsis
- Tumor markers (TMs) are special molecules that help doctors find out if someone has cancer and how they're doing treatment.
- Sometimes these markers can show up even when a person is healthy, which can lead to doctors thinking there's a problem when there's not.
- The review looks at many studies from 1970 to 2023 to understand why false results happen and how knowing more about these markers can help doctors make better decisions.
Genetic Variations in Metallothionein Genes and Susceptibility to Hypertensive Disorders of Pregnancy: A Case-Control Study.
Front Genet
June 2022
Guangxi Key Laboratory of Environmental Exposomics and Entire Lifecycle Health, Guangxi Health Commission Key Laboratory of Entire Lifecycle Health and Care, Guilin Medical University, Guilin, China.
The involvement of oxidative stress in the pathological process of hypertensive disorders of pregnancy (HDP) gives rise to the interest in exploring the association of genetic variations in antioxidant metallothionein () genes with HDP susceptibility. Seventeen single-nucleotide polymorphisms(SNPs) in genes were selected to conduct genotyping based on a case-control study consisting of 371 HDP cases (pregnancy with chronic hypertension (66), gestational hypertension (172), and preeclampsia or preeclampsia superimposed on chronic hypertension (133)) and 479 controls. The association between SNPs in and the risk of HDP was estimated with unconditional logistic regression analysis and further tested with the false-positive report probability (FPRP) procedure.
View Article and Find Full Text PDFAn improved statistical method to identify chemical-genetic interactions by exploiting concentration-dependence.
PLoS One
November 2021
Department of Computer Science, Texas A&M University, College Station, TX, United States of America.
Article Synopsis
- - The text discusses chemical-genetics (C-G) experiments that identify the interactions between bacterial genes and inhibitory compounds, helping to reveal drug targets and related pathways by using a library of modified strains.
- - The methodology includes treating these strains with drugs and using high-throughput sequencing to measure how the relative abundance of different mutants changes, relying on the idea that specific genes may show greater fitness loss when exposed to both the drug and reduced protein levels.
- - A new statistical method called CGA-LMM is introduced to analyze data from C-G experiments more effectively, focusing on how gene abundance varies with drug concentration, and it has successfully identified known target genes in M. tuberculosis for most of the tested antibiotics.
Usefulness of the quantitative measurement of urine protein at a community-based health checkup: a cross-sectional study.
Clin Exp Nephrol
January 2020
Department of Nephrology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Background: The dipstick urinalysis for proteinuria has been used for chronic kidney disease (CKD) screening at community-based health checkups; however, it has major drawbacks in that the result is only semi-quantitative and is influenced by urine concentration.
Methods: We conducted urine protein/creatinine ratio (UPCR) measurements of 590 participants who showed a result of more than trace proteinuria on a dipstick analysis and evaluated the usefulness of UPCR measurements in community-based health checkups.
Results: The UPCR values increased in accordance with the severity of the dipstick test findings, but statistical significance was only obtained between (±) and (1+), between (±) and (2+), and between (±) and (3+) groups.
Measurement of circulating transcript levels (NETest) to detect disease recurrence and improve follow-up after curative surgical resection of well-differentiated pancreatic neuroendocrine tumors.
J Surg Oncol
July 2018
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut.
Background: Recurrence of pancreatic neuroendocrine tumors (pNET) after surgery is common. Strategies to detect recurrence have limitations. We investigated the role of clinical criteria and the multigene polymerase chain reaction-based NETest during post-operative follow-up of pNET.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!